C. Amole

Accelerating access and scale-up of optimized antiretroviral therapy in low-income and middle-income countries: results of a coordinated end-to-end approach

M. Doherty, E. Harris, Katherine Blumer, 2021, AIDS.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Ending AIDS as a public health threat by 2030: Time to reset targets for 2025

M. Dybul, P. Ghys, K. Chalkidou, 2021, PLoS medicine.

Cutting the cost of South African antiretroviral therapy using newer, safer drugs.

M. Moorhouse, M. Boffito, W. Venter, 2016, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.

Michael I. Jordan, S. Delany-Moretlwe, R. Paredes, 2023, The lancet. HIV.

Transitioning Long-Acting Products to a Generic Marketplace: What's Missing?

C. Flexner, R. Bollinger, Linda L Lewis, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High acceptability and viral suppression rate for first-Line patients on a dolutegravir-based regimen: An early adopter study in Nigeria

J. Harwell, O. Agbaji, Jennifer Campbell, 2023, PloS one.